An OEM medical device manufacturer develops or manufactures medical devices, components or complete systems for another company according to an agreed technical and quality framework. Private label medical device manufacturing generally refers to a commercial model in which a product is supplied for sale under another company's brand. However, in regulated medical device markets, branding arrangements can affect which party legally assumes manufacturer responsibilities.

BMAC preparation efficiency should not be evaluated by cell concentration alone. A highly concentrated final sample does not necessarily indicate that a high proportion of the cells originally present in bone marrow aspirate were recovered. For meaningful BMAC evaluation, total cell yield, cell recovery, final volume, cellular composition and reproducibility should be considered together. Commercial BMAC systems can differ substantially in both the percentage of cells recovered and the degree

What Is BMAC? Bone Marrow Aspirate Concentrate, commonly known as BMAC, is a point-of-care biologic preparation produced from autologous bone marrow aspirate. Bone marrow contains a heterogeneous mixture that may include: hematopoietic cells, mesenchymal stromal/progenitor cells, platelets, mononuclear cells, cytokines, growth factors, plasma, red blood cells, and other marrow components. Importantly, mesenchymal stromal/progenitor cells represent only a small fraction of the nucleated cell...